CanaQuest Medical Corp.: CanaQuest Files International Mentanine Patent, a Scientific CBD Formulation for Mental Health )
, an award-winning Life Science/Pharmaceutical company developing formulations combining cannabinoid molecules with pharmaceutical-grade botanical compounds, today announced the filing of its International Patent, trade named
Mentanine®, which has demonstrated at least
10-times (10X) the efficacy compared to Pharma Grade CBD.
Mentanine® - an
International CBD Excellence Award
2020 formulation was scientifically developed through preclinical trials at Western University. Results of its potential effect on anxiety, depression, PTSD, and schizophrenia
have been statistically significant. Our evidence also found that this formulation targeted a specific nuclear cellular receptor involved in anti-inflammatory mechanisms indicating that this formula may also treat inflammatory disorders.
CanaQuest Files International Mentanine(R) Patent, a Scientific CBD Formulation for Mental Health theusnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theusnews.com Daily Mail and Mail on Sunday newspapers.